1. Introduction {#sec1}
===============

Nowadays, several studies have highlighted the vital role of the human microbiome, especially the gut microbiome in regulating human health and disease. Probiotics, such as *Lactobacillus* and *Bifidobacterium*, are crucial part of human intestinal microbes and probiotic supplements could possibly influence the microbiome composition, and consequently conferring several health benefits to the host ([@bib58]). [@bib4] define probiotics as live microorganisms, which can provide a health benefit through improving the host intestinal microbial balance when administered in adequate amounts. These health benefits include alleviation of lactose intolerance, immunomodulation, anti-cancer activity, cholesterol lowering effect, reduction of gastrointestinal disorders including antibiotic-associated diarrhea, increasing the eradication rate of the gastric pathogen *Helicobacter pyloi*, and modulation of the brain function ([@bib24]; [@bib48]; [@bib84]; [@bib62]). It has been reported that probiotics exert not only prophylactic but also therapeutic effects on host gut and immune health, therefore incorporation of probiotic bacteria in fermented food products enhances their value as better functional foods ([@bib56]; [@bib73]). Dairy products such as yoghurt, cheese, ice cream, desserts, cultured milks, or pasteurized unfermented milk are considered as natural vehicles of probiotics ([@bib32]; [@bib35]; [@bib12]). However, many factors have been found to influence the survivability and functionality of probiotics in fermented dairy products like heat treatment, storage temperature, presence of some food additives such as salts and organic acids, that are commonly used in food as a taste enhancer or as a preservative, microbiota competition and possible presence of bacteriocins or other antimicrobials ([@bib77]; [@bib12]; [@bib37]). Transition through gastrointestinal (GI) tract and other factors are also negatively affecting the viability of the cells ([@bib77]). The minimum recommended dose level of probiotic bacteria should be at least 10^6^ cfu/g in the fermented food product at the time of consumption in order to confer their beneficial health effects ([@bib38]; [@bib40]). Therefore, during the production of probiotic food, the viability of the cells within the food and the bioavailability within the host must be taken into consideration ([@bib19]). Interestingly, microencapsulation appears to be one of the promising techniques in protecting probiotic bacteria ([@bib65]). This process can protect the microbial cells from the adverse environmental conditions through entrapment within a matrix of biopolymeric material ([@bib43]; [@bib1]).

So far, various techniques have been considered for the encapsulation of probiotics and the most used techniques are extrusion, emulsion, coacervation, freeze drying and spray drying. Among them, the extrusion method probably is mildest one since it does not require high temperature or any solvents to ensure high cell viability ([@bib45]). Extrusion technique is based on mixing the probiotic cells with the polymeric solution, followed by extrusion into a crosslinking solution such as calcium chloride through a syringe needle or nozzle ([@bib64]). The capsules formed immediately by contacting the cell-polymer droplet with the crosslinking solution. The size of the produced capsules affected by different factors including the nozzle size, viscosity of polymeric solution, and the distance between the syringe and the crosslinking solution ([@bib64]; [@bib49]).

The material used for microencapsulation of probiotics should be natural, biocompatible, permeable to nutrients and metabolites, to provide optimal conditions for functionality of the entrapped cells, and biodegradable to ensure the release of the entrapped cells in the host colon ([@bib64]). Several encapsulating agents have been investigated for the microencapsulation process of probiotics, including polysaccharides originated from seaweed (Κ-carrageenan, alginate), plants (pectin, starch and its derivatives, gum Arabic) or bacteria (gellan, xanthan) and animal proteins (milk proteins, gelatin). Among them, sodium alginate is considered to be the common encapsulating agents that usually used for this purpose, it is a linear heteropolysaccharide, naturally derived from various species of algae, and composed of β-D-mannuronic (M) and α-L-guluronic (G) acids. Alginate microcapsules are formed through ionotropic gelation in presence of divalent cations, commonly calcium ions in the form of CaCl~2~ solution ([@bib64]). Each calcium ion is coordinated to the carboxyl and hydroxyl groups of four α-L-guluronate (G) monomers from two adjacent chains of the sodium alginate polymer forming what called "egg-box" model ([@bib44]). The advantages of this compound include natural identity, biocompatibility, non-toxicity and the relatively simple application in the encapsulation process ([@bib43]; [@bib26]). Despite the previously mentioned advantages, some liabilities are also associated with using alginate in microencapsulation. For example, alginate microcapsules possess a porous structure which does not impart an integrity to the capsule wall leading to less efficient encapsulation ([@bib26]). Moreover, alginate is sensitive to acidic media which make their capsule vulnerable to the stomach juice leading to pre-mature release of the encapsulated probiotic which is supposed to be released in the intestine ([@bib26]).

Blending alginate with other biopolymers could serve as a useful approach in strengthening the microcapsule structure ([@bib43]; [@bib9]). Milk proteins are one of the candidates that can be incorporated with alginate to improve the structure characteristics of the microcapsules that envelope probiotic bacteria ([@bib1]). Milk proteins are caseins and whey proteins, whey protein induce gelation through heating ([@bib1]) and can be used as coat ([@bib30]) or in combination with alginate ([@bib63]) for encapsulation of probiotics. Addition of whey protein isolate to alginate showed 40% improvement in the survivability of *L. acidophilus* in simulated gastric juice ([@bib21]). Moreover, hydrolysis of milk proteins by digestive enzymes potentially generates bioactive peptides that may exert several physiological effects in vivo ([@bib42]). Therefore, milk proteins could be considered as good candidates for encapsulation of probiotics, and as such they are attracting more research attention. In addition to milk proteins, chitosan which is a positively charged linear polysaccharide can also be used with alginate to enhance the physical stability and mucoadhesivity of alginate microcapsules in the colon ([@bib15]; [@bib27]). Coating alginate with chitosan improved the survivability of *L. plantarum* in simulated gastric solution (pH 1.5) by 0.5--2 logs compared to the uncoated capsules ([@bib59]). Dextrin can also be a promising encapsulating agent since it is biocompatible, inexpensive and biodegradable ([@bib20]). Dextrin is a mixture of D-glucose units linked by α-(1→4) or α-(1→6) glycosidic bonds ([@bib78]) and produced by the heating of dry starch in presence of acid or base ([@bib31]). Many reports investigated the promising effect of blending alginate with starch ([@bib74]; [@bib52]). Moreover, [@bib61] demonstrated that encapsulation using maltodextrin and starch (ratio 2:1) maintained the shelf life stability of four types of lactic acid bacteria, *L. plantarum, L. rhamnosus, L. acidophilus, and Bacillus shackletonii* till 12 months at 4 °C. However, to date, no reports investigated the efficacy of combing dextrin with alginate for probiotic encapsulation.

Having inspired by the promising outcomes obtained from the use of alginate combined with milk proteins or coated with chitosan as effective protective and delivery systems for probiotics and the necessity of an efficient, cost effective and food-grade encapsulating agent, the current study aimed to evaluate different combinations of sodium alginate and other adjuvant biopolymers, including skim milk, denatured whey protein, chitosan and dextrin, in order to see which combination was the most efficient for improving the survivability of *L. plantarum* (as a probiotic model) after exposure to different stress factors that may be encountered in real food processing, storage and after ingestion.

2. Materials and methods {#sec2}
========================

2.1. Materials {#sec2.1}
--------------

### 2.1.1. Microbial strains {#sec2.1.1}

The *Lactobacillus plantarum* EMCC1039 was provided by Cairo MIRCEN (Faculty of Agriculture, Ain Shams University, Egypt). *Streptococcus thermophilus* CH-1 and *Lactobacillus acidophilus* CH-2 were provided by Chr. Hansen\'s Lab., Denmark. *Lactobacillus dulbrueckii* subsp. *bulgaricus* Lb-12 DRI-VAC, *Lactobacillus rhamnosus* B-445, *Leuconostoc mesenteroides* 12 DRI-VAC, *Bacillus cereus* B-3711 and *Saccharomyces cerevisiae* Y-2223 were provided by Northern Regional Research Laboratory. Illinois, USA. *Escherichia coli* O157: H7 was provided by Ministry of Health and Population, Egypt. *Aspergillus niger* J5 was provided by Department of Microbiology, Swedish University of Agricultural Sciences. *Staphylococcus aureus* ATCC 25923 generously provided by Department of Microbiology, Faculty of Agriculture, Cairo University.

### 2.1.2. Chemicals {#sec2.1.2}

Sodium alginate and hydrochloric acid pure (35--38%) were purchased from Loba Chemie, Pvt Ltd - Mumbai, India. Fresh liquid skim milk was provided by Faculty of Agriculture, Cairo University, Egypt. White dextrin (C~6~H~12~O~5~)~n~.xH~2~O was provided by Merck (Darmstadt, Germany). Chitosan (Deacetylation 93%; C~6~H~11~NO~4~X~2~; Molecular weight 161.16) was purchased from Oxford Lab Chem (Thane, Maharashtra, India). Whey protein concentrate 80% was purchased from milkiland Intermarket (Poland). Pepsin (1:3,000), calcium chloride and potassium chloride were purchased from Science Lab (Texas, USA). Pancreatin from hog pancreas (5× USP specifications) and bile salt were purchased from BIOBASIC INC (Canada). Peptone was purchased from S D Fine-Chem Limited (Mumbai, India). Sodium chloride, sodium bicarbonate, trisodium citrate and sodium hydroxide were purchased from El Nasr pharmaceutical chemicals (Cairo, Egypt). Glecial acetic acid (extra pure) was purchased from SHAM LAB (Damascus, Syria). De Man Rogosa and Sharpes (MRS) broth and MRS agar were purchased from CONDA (Spain).

2.2. Growth condition {#sec2.2}
---------------------

*L. plantarum* was grown on MRS broth and incubated under aerobic condition for 24 h at 37 °C. The strain was subcultured two or three times in order to obtain high biomasses in the stationary phase then the cell pellets were harvested by centrifugation at 4000 rpm, for 20 min at 4 °C. The pellets washed by sterile saline solution (0.9% (w/v) NaCl) and recovered under the same centrifugation condition then dissolved with an equal volume of sterile saline solution ([@bib22]; [@bib27]). Afterwards, cell suspension was used for encapsulation.

2.3. Composition and preparation of the encapsulating agents {#sec2.3}
------------------------------------------------------------

Four combinations of the encapsulating agents were prepared based on alginate as principle biopolymer combined with another adjuvant biopolymer as follows (all the concentrations that used in this study were chosen after different preliminary optimization experiments):1Sodium alginate-skim milk (Alg-Sm) was prepared according to [@bib68] with some modifications. One part of fresh skim milk was sterilized by autoclaving at 121 °C for 5 min then mixed with 2 parts of 3% (w/v) alginate solution that was sterilized by autoclaving at 121 °C for 15 min.2Sodium alginate-dextrin (Alg-Dex) was prepared according to [@bib54] with some modifications. 3 g (Alg) was dissolved with an equal amount of (Dex) in 100 ml distilled water then the solution was sterilized by autoclaving at 121 °C for 15 min.3Sodium alginate-chitosan (Alg-Ch) capsule. Chitosan was prepared as the method described by [@bib83]. In details, 4% chitosan was prepared by dissolving 0.4 g in 100 ml sterilized distilled water acidified with 0.4 ml of glacial acetic acid because chitosan is insoluble at pH levels above 6.5. After dissolution, pH was adjusted to (5.7--6) by 1 N NaOH. This solution was filtered to remove any remaining insoluble materials.4Sodium alginate-denatured whey protein (Alg-DWP) was prepared by mixing equal volume of 10% (w/v) freshly prepared (DWP) with sterile 3% (w/v) alginate. Briefly, DWP was prepared according to [@bib63] by dissolving 10 g of whey protein concentrate 80% in 100 ml sterile distilled water. The solution was stirred gently for 2 h then rest for 1 h. After that, the solution was exposed to heat treatment in water bath at 90 °C for 30 min.

2.4. Microencapsulation procedure {#sec2.4}
---------------------------------

Generally, the microencapsulation process was performed using the extrusion technique ([@bib28]). One part of the cell suspension was mixed separately with four parts of the freshly prepared encapsulating agents with gentle stirring for 10--20 min. The mixture was then extruded into the hardening solution (CaCl~2~, 0.2 M) through sterile syringe (25 G, 0.5 mm) with gentle stirring for 30 min to ensure complete solidification. In case of Alg-Ch, after extruding the alginate-cells mixture into the crosslinking solution, the harvested alginate microcapsules were then coated with chitosan by immersing (about 12 g capsules) in 100 ml of chitosan solution with gentle stirring for 40 min. The formed microcapsules were harvested by filtration then washed by sterile saline solution and stored at 6 ± 2 °C till be used for further analysis (see [Figure 1](#fig1){ref-type="fig"}).Figure 1Schematic representation of the encapsulation system and the adopted stress conditions.Figure 1

2.5. Enumeration of the microencapsulated cells {#sec2.5}
-----------------------------------------------

The viability of *L. plantarum* was assessed as described by ([@bib15]). In details, one gram of the microcapsules was dissolved in 9 ml of sterile 2% (w/v) tri-sodium citrate solution and vortexed till complete dissolution. After that, the samples were serially diluted to appreciate concentration using 0.1% (w/v) peptone and pour plated in MRS agar. The plates were incubated at 37 °C for 48 h under anaerobic condition. The viable cell number was expressed as colony forming unit per gram of microcapsule (cfu/g).

Encapsulation efficiency (EE) was determined by using the following equation as described by ([@bib27]):$$\text{EE~} = \text{Log}_{10}\text{N}/\text{Log}_{10}\text{N}_{\text{o}}\  \times \ 100\ $$WhereN = the number of the bacterial cells loaded inside the microcapsules.N~o~ = the number of the free bacterial cells added to the biopolymer mixture during the preparation of the microcapsules.

2.6. Morphology and size of capsules {#sec2.6}
------------------------------------

The surface morphology of the capsules was determined by scanning electron microscope (SEM) (model Quanta 250, high resolution field emission gun (HRFEG, Czech). Before SEM analysis, the samples were immersed at first in buffer glutaraldehyde (0.1 M) for 2 h at 4 °C (pH = 7.3), then were post fixed by osmium tetraoxide (0.1 M) for 1 h at 4 °C. After that, the samples were consecutively dehydrated by 30, 50 and 70% ethyl alcohol for 2 min each and remained in 100% ethyl alcohol for 30 min at 4 °C. The samples were then mounted on a piece of adhesive paper and gold coated using a vacuum sputtering coater (Edwards S150A, England).

Particle size of the manufactured dry microcapsules was determined using static laser scattering device (Master sizer 2000, Malvern, UK). The hydrodynamic particle diameter was expressed as volume weighted mean size distribution % (d4,3). The diameter of twenty wet capsules were also evaluated using Calliper (Powerfix, Germany) and the average diameter was measured and recorded.

2.7. Survivability of microencapsulated cells under simulated food processing conditions {#sec2.7}
----------------------------------------------------------------------------------------

### 2.7.1. Different heat treatments {#sec2.7.1}

Sterilized fresh liquid skim milk was inoculated by 10% of the microcapsules then subjected to three different heat treatments that may stimulate the potential stress that can encounter the cells during food manufacturing. The heat treatments include:1.High incubation temperature (40 °C for 24 h).2.Scalding temperature of cheese production (45 °C for 30 min).3.Pasteurization temperature (65 °C for 30 min).

One gram was taken from the sample and the viable cell count was determined as mentioned above in section [2.5](#sec2.5){ref-type="sec"}, the survivability of the encapsulated cells was determined using the following equation as described by [@bib8]:$$\text{Survivability} = \text{log}_{10}\left( {\text{N}_{\text{t}}/\text{N}_{\text{i}}} \right)$$Where N~i~ and N~t~ are the number of the viable cell (cfu/g) at the zero time (initial count) and at various storage time, respectively.

### 2.7.2. Refrigerated storage {#sec2.7.2}

The viability of the encapsulated cells under refrigeration was evaluated by inoculating sterilized skim milk with 10% microcapsules and kept in the refrigerator at 6 ± 2 °C for one month. The viable cell count and survivability were determined everyone week as mentioned above.

### 2.7.3. Freezing storage {#sec2.7.3}

The viability of the encapsulated cells under freezing was evaluated by inoculating 10% of the microcapsules into sterilized skim milk and kept in the ordinary freezer at -18 ± 2 °C for three months. The viable cell count was determined everyone month as mentioned above.

### 2.7.4. Different NaCl concentrations {#sec2.7.4}

Sterilized salted skim milk was prepared by adding sodium chloride at concentrations (1%, w/v), (3%, w/v) and (5%, w/v). Each of the three concentrations was inoculated by 10% of the microcapsules then incubated at 37 °C for 24 h, the viable cell count was determined as mentioned above.

### 2.7.5. Refrigerated storage in different NaCl concentrations {#sec2.7.5}

Sterilized salted skim milk was prepared by adding sodium chloride at concentrations (1%, w/v), (3%, w/v) and (5%, w/v). Each of the three concentrations was inoculated by 10% of the microcapsules then stored at refrigerator for one month at 6 ± 2 ᵒC. The viable count was determined every week as mentioned above.

### 2.7.6. Different concentrations of food-applied organic acids {#sec2.7.6}

Sterilized skim milk supplemented with (1%, w/v) and (2%, w/v) of lactic, citric and ascorbic acids was inoculated by 10% of the microcapsules. The samples were incubated at 37 °C for 24 h, the viable cell count was determined as mentioned above.

### 2.7.7. Metabolites of the other lactic acid bacteria (LAB) {#sec2.7.7}

In this experiment, the effect of the cell free supernatant of *L. acidophilus, L. bulgaricus, L. rhamnosus, S. thermophilus* and *Leuconostoc mesenteroides,* separately was studied on the microencapsulated *L. plantarum.*a)Preparation of cell free supernatant (CFS)

According to [@bib79], all LAB were grown in 11% reconstituted skim milk (obtained from local market) at 37 °C for 24 h. The CFS were obtained by centrifugation (4000 rpm, for 20 min at 4 °C) and sterilized by filtration through a 0.22 μm pore filter. Then CFS was kept frozen.b)For testing the survivability of the microencapsulated cells in presence of the CFS of the other LAB, ten ml of 15% sterilized skim milk (standardized by the CFS to reach 11% total solid) was inoculated with 10% of encapsulated *L. plantarum.* After incubation 24 h at 37 °C, one gram was taken from the sample then the viable cell count and the survivability were determined as described above.

2.8. Survivability of the microencapsulated cells in simulated gastrointestinal tract conditions {#sec2.8}
------------------------------------------------------------------------------------------------

### 2.8.1. Simulated gastric juice (SGJ) {#sec2.8.1}

SGJ was prepared according to the method of [@bib15]. Saline solution (9 g/L NaCl) was adjusted to pH 2.5 (pH of stomach with meal) with 1 N HCl and sterilized by autoclaving at 121 °C for 15 min then pepsin was suspended in the solution to final concentration 3 g/L. SGJ was inoculated with 10% of the microcapsules and incubated at 37 °C. Viable cell count was assessed after 5, 30, 60 and 120 min as described earlier.

### 2.8.2. Simulated intestinal juice (SIJ) {#sec2.8.2}

SIJ was prepared according to the method of [@bib15] and [@bib30]. A solution of 6.5 g/L NaCl, 0.835 g/L KCl, 0.22 g/L CaCl~2~, 1.386 g/L NaHCO~3~ and 3 g/L bile salt was adjusted to pH 7.5 and sterilized by autoclaving at 121 °C for 15 min then pancreatin was suspended in the solution to final concentration 10 g/L. SIJ was inoculated with 10% of the microcapsules and incubated at 37 °C. Viable cell count was assessed after 5, 60, 90 and 120 min as described earlier.

2.9. Production of bioactive compounds {#sec2.9}
--------------------------------------

### 2.9.1. Exopolysaccharides (EPS) {#sec2.9.1}

Isolation of the exopolysaccharides was performed according to [@bib85]: Sterilized skim milk was inoculated by 2% of microcapsules or unencapsulated cells and incubated for 72 h at 37 °C. Twenty mls of 20% trichloroacetic acid was added to the culture in order to precipitate casein followed by centrifugation at 4000 rpm for 20 min at 4 °C. The supernatant was harvested and neutralized to pH 6.8 with 1 N NaOH and subjected to heat treatment at 100 °C for 30 min then recentrifuged at 4000 rpm for 20 min at 4 °C to remove the remaining precipitated insoluble proteins. An equal volume of chilled absolute ethanol was added to the supernatant to precipitate EPS and stored overnight at 6 ± 2 °C. The crude EPS pellet was recovered by centrifugation at 4000 rpm for 20 min at 4 °C and washed with distilled water. The crude EPS was transferred to pre-weighed petriplates and put in the oven at 50 °C to remove the remaining water then weighed. After that, the actual weight of the EPS was calculated by subtracting the weight of the plate with EPS from the weight of the empty plate.

### 2.9.2. Antimicrobial substances {#sec2.9.2}

Sterilized skim milk was inoculated by 2% of microcapsules or unencapsulated cells and incubated for 18 h, 48 h and 72 h at 37 °C. Also, MRS broth was used for evaluation of antimicrobial production using the same inoculation size and incubation conditions. Culture of the *L. plantarum* was centrifuged at 4000 rpm for 20 min at 4 °C. The cell-free supernatant (CFS) was recovered and sterilized by filtration through syringe filter (nylon) 0.22 μm. The filtered CFS was sequentially treated to assay bacteriocin production, the pH was adjusted to 6.0--6.5 with 1 N NaOH followed by heat treatment at 70 °C for 30 min ([@bib5]).

The food-borne pathogens that used were *Escherichia coli* O157:H7, *Staphylococcus aureus*, *Bacillus cereus* and *Aspergillus niger* and *Saccharomyces cerevisiae* as a food spoilage microorganism. All strains were grown in Tryptone soya broth and the pathogenic bacteria incubated at 37 °C for 18 h while the yeast and mould at 25 °C for 3--5 days.

The antimicrobial activity was evaluated by agar well-diffusion method according to [@bib50] by inoculating 10 μL of fresh cultures of the pathogenic organism onto previously poured plate count agar plates for bacteria and potato dextrose agar for yeast and mould using spread plate method. After incubation in the refrigerator for 2 h, five wells of 5 mm diameter aseptically made in each plate and filled with 100 μl of the filtered crude and treated CFS. The plates incubated overnight at 37 °C before measuring the zones of inhibition for bacteria and 72 h at 25 °C for yeast and mould.

2.10. Statistical analysis {#sec2.10}
--------------------------

The data analysis was carried out using CoStat software (StatSoft Inc., Tulsa, USA). Analysis of variance (ANOVA) was applied to determine significant differences (*P \< 0.05*) between results and LSD (Least significant difference) was used to compare means values. The data were expressed as mean ± standard error. All experiments were repeated 3 times (*n = 3*).

3. Results {#sec3}
==========

3.1. Encapsulation efficiency, particle size and capsule morphology {#sec3.1}
-------------------------------------------------------------------

The encapsulation efficiency of the capsules was ranged between 98.11 ± 0.57% and 94.94 ± 1.78% with no significant difference between the different encapsulating agents. Also, the capsule size of the four formulated microcapsules (Alg-Sm, Alg-Dex, Alg-Ch, and Alg-DWP) loaded with *L. plantarum* in the dry state ranged between 501.54 and 800.739 μm while in the wet state it ranged between 1492 and 1635 μm see [Table 1](#tbl1){ref-type="table"} and Figures [2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}. The SEM images of the microcapsules loaded with *L. plantarum* in [Figure 2](#fig2){ref-type="fig"} indicates that all the produced capsules were irregular in shape with rough surface and appeared as drop-like shape with small tail.Table 1Encapsulation efficiency and particle size of different microcapsules.Table 1Encapsulating agentEncapsulation efficiency (%)Particle size (μm)DryWetAlg-Sm96.27 ± 1.63[a](#tbl1fna){ref-type="table-fn"}800.7391553Alg-Dex98.11 ± 0.57[a](#tbl1fna){ref-type="table-fn"}501.5411583Alg-Ch97.26 ± 1.42[a](#tbl1fna){ref-type="table-fn"}519.4811492Alg-DWP94.94 ± 1.78[a](#tbl1fna){ref-type="table-fn"}571.1011635[^1][^2]Figure 2Scanning electron micrograph of (a) Alg-Sm; (b) Alg-Dex; (c) Alg-Ch, and (d) Alg-DWP capsules loaded with *L. plantarum*.Figure 2Figure 3Microscopic images of (a) Alg-Sm; (b) Alg-Dex; (c) Alg-Ch, and (d) Alg-DWP capsules loaded with *L. plantarum*.Figure 3Figure 4Particle size distribution of the microcapsules in dry state.Figure 4

3.2. Survivability of the microencapsulated cells under simulated food processing conditions {#sec3.2}
--------------------------------------------------------------------------------------------

### 3.2.1. Different heat treatments {#sec3.2.1}

Data recorded in [Figure 5](#fig5){ref-type="fig"} revealed that the viability of the all microencapsulated *L. plantarum* increased over the initial count, which was around 10^8^ cfu/g sample, after exposure to 40 °C for 24 h and 45 °C for 30 min. In contrast, the viability of the encapsulated cells drastically decreased (relative to initial count 10^8^ cfu/g sample) after exposure to 65 °C for 30 min. The viability loss of the microencapsulated cells using Alg-Sm was only 1.41 log cycle. However, the viability loss was 2.82, 3.06 and 5.03 log cycle using Alg-Dex, Alg-Ch, and Alg-DWP, respectively. Therefore, Alg-Sm was significantly (*P \< 0.05*) the most effective encapsulating agent in securing *L. plantarum* from the lethal effect of the high temperature.Figure 5Survivability of microencapsulated *L. plantarum* after different heat treatments at 40 °C for 24 h; 45 °C for 30 min; 65 °C for 30 min (initial cell count: ≈10^8^ cfu/g), during refrigerated storage at 6 ± 2 ᵒC for one month (initial cell count: ≈10^9^ cfu/g) and freezing storage at -18 ± 2 °C for three months (initial cell count: ≈10^8^ cfu/g). Error bars represent the standard error of the mean.Figure 5

### 3.2.2. Refrigerated storage {#sec3.2.2}

[Figure 5](#fig5){ref-type="fig"} shows that the viability of all the encapsulated *L. plantarum* increased throughout the storage period over the initial count, which was approximately 10^9^ cfu/g sample. At the end of the storage period (4 weeks), the viable cell count of the encapsulated *L. plantarum* increased by 1.40, 0.88, 0.84 and 0.19 log cycle using Alg-Ch, Alg-Dex, Alg-Sm and Alg-DWP, respectively. From this result we can figure out that all the encapsulating agents keep the viability of the encapsulated cells under the refrigeration condition; however, Alg-Ch significantly (*P \< 0.05*) the most appropriate encapsulating agent for this mission.

### 3.2.3. Freezing storage {#sec3.2.3}

Obtained data in [Figure 5](#fig5){ref-type="fig"} show that the cell load within all the encapsulating agents significantly ($P < 0.05$) decreased throughout the storage period. At the end of the storage period, the maximum viability loss relative to the initial count (approximately 10^8^ cfu/g sample) was about 1.66 and 1.48 log cycle for the cells entrapped within Alg-Sm and Alg-DWP, respectively. On the other hand, the viability loss was 3.44 log and 3.55 log cycle for the cells entrapped within Alg-Dex and Alg-Ch, respectively. Therefore, Alg-DWP and Alg-Sm were significantly (*P \< 0.05*) the most effective encapsulating agents for enhancing the survivability of *L. plantarum* during freezing storage up to 3 months.

### 3.2.4. Different NaCl concentrations {#sec3.2.4}

Results in [Figure 6](#fig6){ref-type="fig"}A show that all the encapsulated cells were able to grow in milk salted with 1% NaCl. However, the capability of the encapsulated cells to grow in 3% and 5% NaCl decreased relative to 1% NaCl. Only *L. plantarum* entrapped within Alg-Dex showed cell reduction by 0.89 and 2.81 log cycle in 3% and 5% NaCl, respectively relative to the initial count (around 10^9^ cfu/g sample). Therefore, Alg-Sm, Alg-Ch or Alg-DWP were the most appropriate encapsulating agents to enhance the tolerance of *L. plantarum* to NaCl concentrations up to 5%.Figure 6Survivability of the microencapsulated *L. plantarum* (A) after incubation at 37 °C for 24 h in different NaCl concentrations (B) during refrigerated storage at 6 ± 2 °C for one month in different NaCl concentrations. (C) after incubation at 37 °C for 24 h in different concentrations of food-applied organic acids. (D) after incubation at 37 °C for 24 h with the metabolites of the other LAB. Error bars represent the standard error of the mean. Error bars represent the standard error of the mean. Initial cell count: ≈10^9^ cfu.Figure 6

### 3.2.5. Refrigerated storage for one month in different NaCl concentrations {#sec3.2.5}

[Figure 6](#fig6){ref-type="fig"}B shows that the survivability of the encapsulated *L. plantarum* increased over the initial count, which was approximately 10^9^ cfu/g, during the refrigerated storage in different NaCl concentration. However, by increasing the salt concentration, the survivability of the encapsulated cells decreased. Our results revealed that at the end of the storage period, in 1% NaCl the viable cell count of the encapsulated *L. plantarum* increased by 1.69, 0.93, 0.75 and 0.60 log cycle using Alg-Ch, Alg-Dex, Alg-DWP and Alg-Sm, respectively. While, in 3% NaCl, the viability also increased by 0.97, 0.70, 0.12 and 0.05 log cycle for Alg-Ch, Alg-Dex, Alg-Sm and Alg-DWP, respectively. On the other hand, in 5% NaCl, only the cells entrapped within Alg-Ch increased by 0.42 log cycle; however the cells using the other encapsulating agents showed slightly viable cell reduction by 0.49, 0.62, 0.95 log cycles for Alg-DWP, Ag-Dex and Alg-Sm, respectively. Based on the above mentioned, all the encapsulating agents secured 10^7^ cfu/g sample in presence of NaCl concentration up to 5% under refrigerated storage for 4 weeks; however, Alg-Ch appeared to be the most appropriate one.

### 3.2.6. Different concentrations of food-applied organic acids {#sec3.2.6}

[Figure 6](#fig6){ref-type="fig"}C describes the tolerance of the encapsulated *L. plantarum* to different organic acids (including citric, lactic and ascorbic acids) after incubation at 37 °C for 24 h. In case of 1% citric acid (pH 3.46), *L. plantarum* encapsulated with Alg-Dex, Alg-Sm and Alg-Ch grew, and the viable count increased over the initial count, which was approximately 10^9^ cfu/g, by 1.68, 0.72 and 0.15 log, respectively. However, the number of cells entrapped within Alg-DWP decreased by 0.35 log cycle. On the other hand, in case of 2% citric acid (pH 3.02) the viable count of *L. plantarum* in all microcapsules declined, the minimum cell reduction was 0.43 log cycle for Alg-Dex while the maximum cell reduction was 2.44 cycle for Alg-DWP. It appears that Alg-Dex showed higher relative cell viability in 1% and 2% citric acid than the other encapsulating agents.

In case of 1% lactic acid (pH 3.17), Alg-Sm was the only encapsulating agent that permitted the growth of *L. plantarum* where the viable count increased by 1.48 log cycle over the initial count, which was approximately 10^9^ cfu/g. However, the cell count within the Alg-Dex, Alg-DWP and Alg-Ch decreased by 0.44, 0.69 and 2.09 log cycle, respectively. In case of 2% lactic acid (pH 2.87), the number of all encapsulated *L. plantarum* sharply declined by 2 log cycle for Alg-Sm and Alg-Dex, 3 log cycle for Alg-DWP and 4.4 log cycle for Alg-Ch. From the above mentioned, Alg-Sm was the most appropriate encapsulating agent for protection of *L. plantarum* from lactic acid containing environment up to 2%.

Regarding ascorbic acid, all the encapsulated *L. plantarum* showed better growth in skim milk containing (1--2%) ascorbic acid (pH 4.44 and 3.78, respectively) than citric and lactic acids. However, encapsulation using Alg-Ch increased the growth of *L. plantarum* by 2.81 and 3.00 log cycle over the initial count that was 10^9^ cfu/g in 1 and 2% ascorbic acid, respectively. This growth enhancement was greater than that occurred in the other encapsulating agents that used in this study.

### 3.2.7. Metabolites of the other lactic acid bacteria {#sec3.2.7}

All the encapsulating agents maintained the viability of the entrapped *L. plantarum* after incubation with the metabolites of the other LAB. However, encapsulation using Alg-Dex significantly (*P \< 0.05*) enhanced the growth of the entrapped *L. plantarum* than the other encapsulating agents see [Figure 6](#fig6){ref-type="fig"}D.

3.3. Survivability of the microencapsulated cells in simulated gastrointestinal conditions {#sec3.3}
------------------------------------------------------------------------------------------

[Figure 7](#fig7){ref-type="fig"} presents that after exposure to SGJ for 120 min, the viable cell count of the all encapsulated *L. plantarum* reduced from the initial count (around 10^8^ cfu/g). The viability loss was 1.24 and 1.71 log cycle for the cell entrapped within Alg-Ch and Alg-Sm, respectively. However, the cell reduction was about 2.24 and 2.47 log cycle for Alg-DWP and Alg-Dex, respectively Therefore, Alg-Ch was the most efficient encapsulating agent for maintaining the viability *L. plantarum* under simulated gastric condition followed by Alg-Sm. However, after exposure to SIJ for 120 min, the viable cell count of the encapsulated *L. plantarum* reduced from the initial count (around 10^9^ cfu/g) by only 0.68 log cycle for the cells entrapped within Alg-Sm while the reduction was 1.55, 2.12 and 2.37 log cycle for the cell entrapped within Alg-Ch, Alg-Dex and Alg-DWP, respectively. Based on that, Alg-Sm microcapsules appeared to be significantly (*P \< 0.05*) the most efficient encapsulating agent for maintaining the survivability of *L. plantarum* up to 10^7^ cfu/g capsule under simulated intestinal condition.Figure 7Survivability of the microencapsulated cells after exposure to simulated gastric juice (SGJ) (a) and simulated intestinal juice (SIJ) (b). Error bars represent the standard error of the mean. Initial cell count: ≈10^8^ cfu/g.Figure 7

3.4. Production of bioactive compounds {#sec3.4}
--------------------------------------

*L. plantarum* was capable of excreting polysaccharides with no significant difference between the unencapsulated cells and all the tested encapsulating agents. The amount of the exopolysaccharide produced by the unencapsulated cells was 0.44 ± 0.16 g/100 ml skim milk and it was about 0.38 ± 0.01, 0.34 ± 0.02, 0.35 ± 0.02, and 0.465 ± 0.09 g/100 ml skim milk for the cells encapsulated with Alg-Sm, Alg-Dex, Alg-Ch and Alg DWP, respectively ([Table 2](#tbl2){ref-type="table"}).Table 2Exopolysaccharide production by *L. plantarum* in skim milk (g/100 ml skim milk).Table 2Encapsulating agentExopolysaccharide yieldUnencapsulated cells0.44 ± 0.16[a](#tbl2fna){ref-type="table-fn"}Alg-Sm0.38 ± 0.01[a](#tbl2fna){ref-type="table-fn"}Alg-Dex0.34 ± 0.02[a](#tbl2fna){ref-type="table-fn"}Alg-Ch0.35 ± 0.02[a](#tbl2fna){ref-type="table-fn"}Alg-DWP0.465 ± 0.09[a](#tbl2fna){ref-type="table-fn"}[^3][^4]

However, the CFS of *L. plantarum* grown in skim milk did not show any antimicrobial activity against the tested pathogens. Due to this result, the unencapsulated and the encapsulated *L. plantarum* were evaluated for production of antimicrobial substances in MRS broth. The results showed that only the crude CFS of *L. plantarum* grown in MRS broth for 72 h at 37 °C was effective against *B. cereus, E. coli* O157: H7 and *Staph. aureus,* but it did not show any antimicrobial activity against *Sacch. cereviciae* and *A. niger.* In addition, it could be confirmed that, there was no significant difference between the unencapsulated and the entrapped cell in production of the antimicrobial substances. Also, there was no significant difference between using all the encapsulating agents ([Table 3](#tbl3){ref-type="table"} and [Figure 8](#fig8){ref-type="fig"}).Table 3Antimicrobial activity of cell free supernatant of *L. plantarum* grown in MRS broth media for 72 h at 37 °C.Table 3Encapsulating agentSize of Inhibition Zones (mm)*B. cereusE. coli* O157: H7*Staph. aureusSacch. cerevisiaeA. niger*Unencapsulated cells20 ± 0.00^a^15.67 ± 2.33^ab^17.33 ± 1.45^ab^0.00.0Alg-Sm20 ± 0.00^a^15.67 ± 2.33^ab^16.67 ± 0.88^ab^0.00.0Alg-Dex18.33 ± 0.88^ab^16.33 ± 1.86^ab^15 ± 2.89^b^0.00.0Alg-Ch20 ± 0.00^a^14.67 ± 1.45^b^15.67 ± 0.67^ab^0.00.0Alg-DWP17.33 ± 1.45^ab^16 ± 2.08^ab^15 ± 0.00^b^0.00.0[^5][^6]Figure 8Antimicrobial activity of cell free supernatant of free and microencapsulated *L. plantarum*.Figure 8

4. Discussion {#sec4}
=============

Microencapsulation technology is regarded as one of the most useful methods for enhancing the stability and viability of probiotics under harsh environmental conditions, facilitating handling of cells with constant characteristics and allowing a controlled dosage ([@bib65]; [@bib36]; [@bib39]). Several studies have verified that encapsulated bacteria survive better than unencapsulated cells during exposure to different lethal conditions, through high temperature ([@bib27]), freezing ([@bib34]), during storage ([@bib16]), during gastric transit ([@bib70]) and in high bile salt concentration ([@bib15]). Several encapsulating materials have been tested for their ability to improve the viability of many probiotic strains. However, few studies have investigated the comparison between different encapsulating agents in different harsh conditions and there are still challenges to find the proper encapsulating agent ([@bib17]). Therefore, in the present study, *L. plantarum* was encapsulated using alginate-based material combined with different biopolymers, including skim milk, dextrin, denatured whey protein or coating with chitosan, undergoing extrusion technique. The survivability of the encapsulated cells was evaluated under different stress conditions that may be encountered in real food processing and after ingestion. Moreover, they were evaluated for production of different bioactive compounds like exopolysaccharides and antimicrobial substances.

Encapsulation efficiency is one of the most important parameters for determining the efficacy of the encapsulation process and the selected encapsulating agent ([@bib11]). Our findings demonstrate that the encapsulation efficiency of the capsules loaded with *L. plantarum* was ranged between 98.11% and 94.94% with no significant difference upon using the four encapsulating agents. Similar results in different alginate concentration blended with psyllium and fenugreek were reported by [@bib33]. The high encapsulation efficiency (\>92%) can be explained by the fact that cell culture from stationary phase exhibits better survivability than that from log phase ([@bib37]). The mild encapsulation operation could also explain the high encapsulation efficiency ([@bib23]). Other studies reported that using extrusion technique is very gentle on probiotic encapsulation and produce high encapsulation efficiency. For instance, [@bib68] found that the encapsulation efficiency of Alg-milk microsphere loaded with *L. bulgaricus* was around 100%. Furthermore, the encapsulation efficiency of alginate-human-like collagen microspheres loaded with *Bifidobacterium longum* BIOMA 5920 ranged between 92--99.2% ([@bib72]). It is axiomatic to indicate that high encapsulation efficiency was correlated with a good entrapment of the bacteria into the microcapsules ([@bib10]).

All the produced capsules in this study were observed irregular in shape with rough surface under the SEM. This could be attributed to an artifact resulting from sample preparation process or the high vacuum applied during SEM analysis. In addition, the capsules appear as drop-like shape with small tail. This could be a consequence of the high surface tension of the used crosslinking solution (CaCl~2~), resulting in formation of imperfect spherical capsule ([@bib51]). The shape of the microcapsules formed in this study is coincidence to other studies ([@bib57]; [@bib72]). The particle size of the four formulated capsules (Alg-Sm, Alg-Dex, Alg-Ch, and Alg-DWP) loaded with *L. plantarum* in the dry state ranged between 501.54 and 800.739 μm while in the wet state it ranged between 1492 and 1635 μm. These results come in agreement with [@bib2] who found that the Alg-Ch capsules had a diameter of around 2 mm before drying and 0.98 and 1.34 mm after drying and [@bib27] who prepared capsules ranged in size between 1312.4 and 1335.7 μm. Also, [@bib57] prepared alginate and alginate + starch capsules with size ranged between 2-3 mm. [@bib72] found that the particle size of alginate-human-like collagen microspheres ranged between 300--600 μm. On the other hand, [@bib33] prepared alginate and alginate-psyllium capsules with size ranged between 80-300 μm using extrusion technique. Based on the above mentioned, there was a high variation in bead sizes and this variation could be due to the different polymer concentration and composition ([@bib33]). Application of encapsulating probiotics in food industry is a challenge mainly due to the large size of bacterial cells (typically 1--4 μm) that subsequently lead to production of large capsules, which may negatively affect the sensory qualities of foods ([@bib17]; [@bib39]). In fact, extrusion technique produce capsules with size not smaller than 300 μm ([@bib9]). The optimum size of the microcapsules until now remains debatable as it varies according to the applications ([@bib66]). [@bib14] and [@bib27] found that larger microcapsules provide better protection to the entrapped cells against harsh environment. On the other hand, [@bib52] reported that the acceptable capsule size for food application should not be up to about 80 μm in order to avoid a negative sensory effect on the product. In the present study, the prepared capsules seem to be sufficiently large for achieving good cell loading and protection of cells against detrimental environmental conditions as will be verified from the encapsulation efficiency and tolerance to different stress conditions which will be discussed later.

Upon studying the survivability of the microencapsulated cells under different heat treatments, it was demonstrated that the temperatures 40 and 45 °C seem to be not lethal for the encapsulated *L. plantarum.* This observation may be regarded to the fact that the maximum growth temperature of *L. plantarum* is 45 °C ([@bib81]). Similarly, [@bib60] reported that *L. plantarum* encapsulated with sodium alginate survived by 100% and 90% after heat treatment at 40 and 50 °C, respectively for 20 min. On the other hand, after exposure to the pasteurization temperature (65 °C for 30 min), Alg-Sm was the only encapsulating agent that secured 10^6^ cfu/g for *L. plantarum*, which is the recommended dose level of probiotics in the product to be effective and perform their function ([@bib75]; [@bib6]). Other studies also showed that using skim milk in the encapsulation system enhanced the heat tolerance of probiotic bacteria, [@bib80] confirmed that the incorporation of gellan gum and skim milk powder with the alginate leads to the formation of a strong structure that protect *L. kefiranofaciens* M1 against heat treatment reached 70 °C. In addition, encapsulation using skim milk and cheese whey had a protective effect for *L. paracasei* FNU against heating at 65 °C for 30 min in comparison with unencapsulated cells, viable cell count of the encapsulated cells was 6.06 ± 0.14 log cfu/ml, while the free cells was 5.91 ± 0.16 log cfu/ml ([@bib37]).

Interestingly, on studying the survivability of the encapsulated cells during the refrigerated storage for one month, the viability of the encapsulated *L. plantarum* increased over the storage period. This could be due to the fact that *L. plantarum* was capable of growing at 8 °C in UHT milk ([@bib53]). In addition, the encapsulated cells were stored in skim milk that could be a nutritional factor to enhance the growth of the encapsulated cells, which was not adopted by the other relevant studies. All the encapsulating agents that are used in this study were efficient in enhancing the viability of *L. plantarum* during the refrigerated storage at 6 ± 2 ᵒC up to one month. However, Alg-Ch was significantly (*P \< 0.05*) the most appropriate one. [@bib76] found that Alg-Ch was effective in maintaining the stability of *L. plantarum* TN8 (approximately 9.34 cfu/ml) under refrigerated storage for 30 days and showed a viability loss from 9.34 to 7 log cfu/ml at the end of the storage period (60 days) in comparison with the viability of the unencapsulated cells that was just 10^1^ cfu/ml after 30 days, that\'s due to the protection thicker membranes with chitosan. Also, [@bib8] reported that using pectin and Alg-Ch as encapsulating agents showed little loss of *L. plantarum* BL011 survival after 38 days under refrigerated storage at 4 °C by 1.95 ± 0.08 and 2.17 ± 0.49 log, respectively as compared with the other tested materials. Coating alginate with chitosan could probably serve as a superior barrier as it strengthen the capsule structure ([@bib27]). It appears that milk proteins are the most efficient in protecting *L. plantarum* during freezing storage up to 3 months. This could be due to the adsorption of milk proteins on the cell surface that leads to a partial efflux of water from the cell, thus inhibiting the growth of ice crystals inside the cell, which subsequently reduce cell injury and cell loss ([@bib80]).

The finding that the survivability of the encapsulated cells decreased by increasing salt concentration upon incubation at 37 °C for 24 h or during refrigerated storage for one month, could be attributed to the ion exchange between sodium and calcium ions in the alginate matrix, leading to swelling and destabilization of calcium alginate capsules and affecting the viability of entrapped cells ([@bib29]). Despite that the cell reduction was still in the acceptable limit which is 10^6^ cfu/g product. Few reports investigated the tolerance of microencapsulated bacteria to high salt concentration. [@bib7] previously reported that microencapsulation using whey protein isolate and gum Arabic undergoing coacervation technique enhanced the survival of *L. paraplantarum* B1 and *L. paracasei* E6 by 4 and 3 logs, respectively after exposure to 9% NaCl for 3 h in comparison with the unencapsulated cells. In addition, [@bib55] found that microencapsulation using soy milk and gum Arabic undergoing spray drying technique showed better stability to *L. acidophilus* during storage in (1--5%) NaCl at 5 °C when compared with unencapsulated cells, suggesting that microencapsulation could be an innovative delivery system for probiotics in salted products. However, [@bib13] noted no growth for both the unencapsulated and the encapsulated cells after exposure to 5% NaCl and proved that microencapsulation by spray drying with whey did not alter the sensitivity of *Bifidobacterium* Bb-12 to 5% NaCl. The authors claimed that the reason for that may regarded to the sublethal injuries in cells due to spray drying and the high susceptibility of the culture in its own free form to NaCl, indicating that the nature of the bacterial strain, the encapsulation technique and the materials that used for the encapsulation play a role in the successful of the encapsulation process.

Some food and beverages require the addition of some organic acids for imparting organoleptic characteristics, preservation or increasing the nutritional value. Among the common organic acids used for that purpose are citric, lactic and ascorbic acids. Therefore, it was obvious to test the survivability of the microencapsulated cells in such potential matrix. Our results demonstrated that Alg-Dex showed higher relative cell viability for *L. plantarum* in 1% and 2% citric acid than the other encapsulating agents. That is due to the capability of *L. plantarum* to utilize citric acid and grew faster in presence of glucose in the medium ([@bib41]). Therefore, *L. plantarum* could use the glucose molecules that are available in the dextrin structure. Also, Alg-Sm was the more appropriate encapsulating agent in protection of *L. plantarum,* from lactic acid containing environment up to 2%. These results could be explained by the denser hydrogel network formed by alginate (3%) and the supporting materials, milk proteins or chitosan. That strengthen the alginate structure and subsequently could reduce the permeability of the acidic materials into the encapsulated capsules ([@bib68]; [@bib33]). Similarly, [@bib55] found that protein- and soy-milk containing capsules provide better protection to *L. acidophilus* from the low pH of lactic, citric and acetic acids. Ascorbic acid (Vitamin C) is used as food additive in food products e.g., fruit juices. It has antioxidant activity and acts as oxygen scavenger. Therefore, all the encapsulated *L. plantarum* showed better growth in skim milk containing (1--2%) ascorbic acid than citric and lactic acids. This result could be due to the oxygen scavenger activity of ascorbic acid that reduced the oxygen content in the growth medium and subsequently enhanced its growth ([@bib67]). Based on our results, the growth rate is dependent on the identity and the concentration of the organic acid.

Combining starter culture and probiotics during manufacturing of a fermented product may result in positive or negative interaction depending on the bacterial strain used ([@bib46]). All the encapsulating agents secured 10^8^ cfu/g sample; however, *L. plantarum* encapsulated with Alg-Dex significantly (*P \< 0.05*) showed greater growth in presence of the metabolites of *L. rhamnosus*, *S. thermophilus*, *Leu. mesenteroides*, *L. bulgaricus* and *L. acidophilus* than that entrapped within the other encapsulating agents. In fact, the calcium alginate matrix destabilized in presence of chelating agents like lactate, citrate and phosphate, which are commonly excreted during the LAB fermentation ([@bib33]). In addition, *L. plantarum* grows more optimal on glucose as a carbon source ([@bib71]). Therefore, *L. plantarum* could ferment glucose that present in the dextrin structure. Also, the growth of *L. plantarum* could be stimulated by the metabolites of the other LAB in presence of glucose molecules like that happened with [@bib71] who found that *L. plantarum* was stimulated by *S. cerevisiae* in presence of glucose concentration above 2 g/l. There is little information available regarding the possible interactions among lactic acid starter and probiotic bacteria. [@bib25] found that microencapsulation using sodium alginate provided better protection for *L. acidophilus* from the harmful effect of *Lactococcus lactis* and vice versa during the refrigerated storage of Talaga cheese for 30 days.

One of the main objectives of microencapsulation is providing protection of probiotic cells during exposure to low pH gastric environment ([@bib11]). For probiotics to perform their function in human (prevention of gastrointestinal diseases), they have to reach the small intestine and colonize the host in appropriate number, which is 10^6^-10^7^ cfu/g ([@bib69]). Microencapsulation appeared to be a promising technique for improving the survivability of probiotics under gastrointestinal tract conditions ([@bib70]). According to our results, Alg-Ch and Alg-Sm were the most appropriate encapsulating agents for maintaining the survivability of *L. plantarum* under simulated gastric condition. Therefore, chitosan and milk proteins played the key role in maintaining the viability of the cells under gastric condition. The cationic nature of chitosan and its ability to buffer acid ([@bib18]) may limit the interaction between the cells and the acidic environment ([@bib15]). [@bib27] reported that coating alginate microcapsules with chitosan resulted in a great survival of *L. plantarum* LAB12 that came in accordance with our finding. Likewise, [@bib59] found that microencapsulation in alginate coated chitosan improved the survivability of *L. plantarum* by about 0.5--1 log cycle compared with alginate alone. This result comes from the electrostatic interactions between chitosan and alginate that leads to the formation of a strong membrane on the surface of the capsule, which subsequently reduces the likelihood of leakage of the entrapped cells. Also, milk proteins can improve the survival of bacteria in simulated gastric juice due to the dense protein matrix that may reduce the diffusion rate of the acid into the microcapsules ([@bib68]; [@bib70]). Alg-Sm microcapsules appeared to be significantly (*P \< 0.05*) the most resistant encapsulating agent to maintain the survivability of *L. plantarum* under simulated intestinal condition. This result came in accordance with [@bib68] who found that Alg-Milk capsules tolerated the high bile salt solution and improve the survival of *L. bulgaricus* after exposure to (1--2%) bile salt solution. The result also revealed that the protection provided using the four encapsulating agents secured 10^7^ cfu/g sample, this viable cell count is within the recommended probiotic dose level to be effective as indicated before. Therefore, all capsules will take more time to be disintegrated and controlled the release of the entrapped cells, thus subsequently shorten the exposure time to the detrimental effect of the intestinal fluid ([@bib27]).

This study demonstrated that *L. plantarum* produce extracellular polysaccharides (approximately 0.44 g/100 ml skim milk), also [@bib82] reported that *L. plantarum* ZDY2013 produce exopolysaccharide and the yield was 0.4294 ± 30.3 g/l MRS. Fascinatingly, there was no significant difference in the production of EPS between the unencapsulated and the encapsulated cells. In addition, according to the data obtained from studying the ability of the encapsulated cell to produce antimicrobial compounds, the cell free supernatant of *L. plantarum* grown in MRS broth medium at 37 °C for 72 h was active against *B. cereus*, *Staph. aureus* and *E. coli* O157: H7*.* However, the CFS of *L. plantarum* grown in MRS at 37 °C after 18 and 48 h and in fresh skim milk under the same condition were ineffective against the tested food spoilage strains. These findings infer that the antimicrobial effect against *B. cereus*, *Staph. aureus* and *E. coli* O157: H7 were regarded to the accumulation of the organic acids in the medium during the incubation period (72 h at 37 °C) not to the bacteriocins. This observation come in agreement with [@bib3] who suggested that the antimicrobial activity of *L. plantarum* depends on a pH reduction effect of supernatants and/or on the presence of organic acids. The antimicrobial effect of the organic acids result from their ability to penetrate the cell cytoplasmic membrane in the undissociated form leading to reduction in the intracellular pH due to accumulation of the acids in the cell cytoplasm and ultimately cell death ([@bib55]). [@bib47] found that the supernatant (pH 3.6) of *L. plantarum* LZ206 possess antimicrobial activity against various food borne pathogens including Gram-positive bacteria (*Staphylococcus aureus* and *Listeria monocytogenes*) with inhibition zone 10--15 and 15--20 mm, respectively, Gram-negative bacteria (*Escherichia coli* and *Salmonella enterica*) with inhibition zone 15--20 mm and 20--25 mm, respectively, that is approximately similar to what we have found with the tested pathogens. Furthermore, there was no significant difference between the unencapsulated and the encapsulated cells in production of antimicrobial substances. This indicates that microencapsulation does not affect the functionality and the metabolic activity of the entrapped cells. Our findings come in agreement with [@bib80] who found that the encapsulation technique does not affect the anti-colitis activity of the entrapped cells. Finally, our results showed a differential behavior among the different encapsulating agents toward the different stress conditions. This means that each encapsulating agent can secure protection to the encapsulated probiotic in a specific stress evaluation. However, based on our findings, Alg-Sm could be the promising capsule for enhancing the stress tolerance of *L. plantarum* during storage, food processing and transition through gastrointestinal tract conditions. Overall, the type of final application and the potential stress are the factors that can determine the appropriate type of the encapsulating agent. This comprehensive study provides useful guidelines for the application of probiotic encapsulation in the food industry, of course, the simulation studies add value during development of new technology; however, it is not enough and further studies need to be performed to monitor the efficacy of the studied encapsulated materials in real food system and in vivo, using animal models. The organoleptic characteristics and the shelf life of the encapsulated products should also be tested since the sensory evaluation of products with microencapsulated probiotic bacteria will reveal the consumer response to the texture and the changes in organoleptic characteristics of the product.
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[^1]: Data were expressed as mean ± standard error.

[^2]: Values with different superscript letters are significantly different (*P \< 0.05*).

[^3]: Data were expressed as means$\  \pm \ $standard error of three replicates ($\text{n} = 3$).

[^4]: Value represents no significant difference between the data $\left( \text{P} \leq 0.05 \right.$).

[^5]: Data were expressed as means$\  \pm \ $standard error of three replicates ($\text{n} = 3$).

[^6]: ^a-b^Values with different superscript letters are significantly different (*P \< 0.05*).
